相关实验视频

Updated: May 11, 2025

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

SLC25A19是肝细胞癌的关键预后标志物

Liang Chen¹, Xiaomei Ying², Jiaheng Xie³

¹Department of Hepatobiliary and Pancreatic Surgery, Conversion Therapy Center for Hepatobiliary and Pancreatic Tumors, First Hospital of Jiaxing, Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, People's Republic of China.

Scientific reports

|April 18, 2025

概括

在肝细胞癌 (HCC) 中,SLC25A19蛋白过度表达,与预后不佳和免疫检查点基因表达相关. 这一发现为HCC诊断,预后和免疫治疗策略提供了潜力.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
生物化学生物化学

背景情况:

蛋白质SLC25A19有助于提氨酸铁酸盐 (TPP) 穿过细胞膜的运输.
在癌症发展和进展中SLC25A19的作用在很大程度上是未被探索的.
了解SLC25A19在癌症中的功能对于确定新的治疗点至关重要.

研究的目的:

为了研究SLC25A19.1的胰癌表达和预后意义.
评估SLC25A19在肝细胞癌 (HCC) 的诊断和预后价值.
探索SLC25A19与瘤免疫微环境的关联,并确定HCC的潜在治疗策略.

主要方法:

利用癌症基因组图谱 (TCGA) 数据库对33种癌症类型的RNA-seq,生存和临床病理学数据.
对SLC25A19进行了跨癌症的表达和生存分析,重点是HCC.
分析了与免疫检查点基因相关的SLC25A19表达,确定了相关药物,并在HCC组织中使用PCR和Western Blotting验证了表达.

主要成果:

在HCC中,SLC25A19显著过度表达,并与不良的患者预后有关.
在HCC中SLC25A19的高表达与免疫检查点基因的高表达相关.
通过PCR和Western Blotting证实,与相邻的正常组织相比,HCC组织中SLC25A19的上调.

结论:

在HCC中SLC25A19过度表达表明预后不佳,并可能在免疫逃避中发挥作用.
SLC25A19可以作为HCC的诊断生物标志物和治疗点.
这些发现表明SLC25A19参与HCC免疫疗法,并为向药物选择提供基础.

关键词:

癌症代谢癌症代谢肝细胞癌是肝细胞癌.在 SLC25A1919 中.溶解物载体是溶解物中的载体.氨酸铁酸酸盐是什么

更多相关视频

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish

Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish

Published on: April 1, 2021

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...